John Hardy on Charting Genetic Diversity—First Haplotype Map Appears
COMMENT With the completion of the HapMap and its commercialization by Illumina and Affymetrix, it should be possible for researchers to find susceptibility alleles which have an odds ratio of >2 for any disorder, including Alzheimer disease, over the next ...